Skip to main content

Co-Circulating Influenza and SARS-CoV-2 Jan 2023 header image

DYK? Co-Circulating Influenza and SARS-CoV-2 – HealthDirect Pharmacy Services

January 10, 2023

CDC Recommendations: Per the CDC National Center for Immunization and Respiratory Diseases (NCIRD), the following practices should be considered when SARS-CoV-2 and Influenza viruses are found to be co-circulating based upon local public health surveillance data and testing at local healthcare facilities. While these considerations are specific to care of residents residing in nursing homes,…

di you know: direct oral anticoagulant blog header image

Did You Know? Direct Oral Anticoagulants (DOAC’s)

July 8, 2022

What are DOAC’s and what are they used for? Indication Apixaban (Eliquis) Dabigatran (Pradaxa) Edoxaban (Savaysa) Rivaroxaban(Xarelto) Nonvalvular AtrialFibrillation (AF) 5 mg bid 150 mg bid 60 mg once daily 20 mg once dailywith largest meal(food increasesbioavailability) VTE Treatment 10 mg bid for 7 days, then 5 mg bid; may reduce to 2.5 mg bid…

Product Focus: PAXLOVID

January 4, 2022

PAXLOVID – Oral Antiviral Treatment for COVID-19 The FDA has recently granted emergency use authorization (EUA) for PAXLOVID. Paxlovid is nirmatrelvir tablets co-packaged with ritonavir tablets, both antiviral agents. Both agents must be administered together. In clinical trials, PAXLOVID significantly reduced the risk of hospitalization or death for any cause by 89% compared to placebo…